Perrigo (PRGO) to Acquire Omega Pharma in ~$4.5B Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Goldman Sachs Comment on Perrigo's (PRGO) Omega Deal and Quarterly Results
November 6, 2014 2:21 PM ESTGoldman Sachs maintained a Neutral rating on Perrigo Co. (NYSE: PRGO) with a price target of $145. Earlier Perrigo reported Q1 results and announced a deal to acquire Omega. In the view of analyst Jami Rubin, Omega is a good strategic fit, but he noted Q1 was another weak quarter.
"While we dont take a view on the likelihood of the deal closing, strategically we think the deal makes sense and as it would provide PRGO with the geographic... More
Perrigo (PRGO) Misses Q1 EPS by 4c
November 6, 2014 6:33 AM ESTPerrigo (NYSE: PRGO) reported Q1 EPS of $1.40, $0.04 worse than the analyst estimate of $1.44. Revenue for the quarter came in at $951.5 million versus the consensus estimate of $997.9 million.
For earnings history and earnings-related data on Perrigo (PRGO) click here.
... More